GAMMA Investing’s Structure Therapeutics GPCR Stock Holding History

GAMMA Investing’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$44.9K	Sell	836 -163	-16%	-$7.21K	﹤0.01%	2377
2026 Q1	$48.2K	Buy	999 +69	+7%	+$4.72K	﹤0.01%	2203
2025 Q4	$64.7K	Buy	930 +112	+14%	+$4.57K	﹤0.01%	1890
2025 Q3	$22.9K	Buy	818 +337	+70%	+$6.71K	﹤0.01%	2448
2025 Q2	$9.98K	Sell	481 -26	-5%	-$572	﹤0.01%	2806
2025 Q1	$8.78K	Sell	507 -642	-56%	-$15.7K	﹤0.01%	2810
2024 Q4	$31.2K	Buy	1,149 +1,122	+4,156%	+$39.8K	﹤0.01%	2020
2024 Q3	$1.19K	Buy	27 +11	+69%	+$425	﹤0.01%	3209
2024 Q2	$628	Buy	16 +6	+60%	+$246	﹤0.01%	3162
2024 Q1	$429	Buy	10 +1	+11%	+$42	﹤0.01%	3127
2023 Q4	$393	Buy	+9	New	+$516	﹤0.01%	3006

Other funds holding GPCR

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return

Ares Financial Consulting Calabasas, California $139M AUM